Company Search:
Advanced Search
Sponsored Links
Interleukin Genetics, Inc. Company Snapshot
Interleukin Genetics, Inc. operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Interleukin Genetics with three other companies in this sector in the United States: Akers Biosciences Incorporation (2016 sales of $2.96 million of which 100% was Diagnostic Screening), Vermillion Inc ($2.64 million of which 100% was Novel Diagnostic Test), and Immunomedics, Inc. ($3.23 million of which 100% was Biopharma Products).

Sales Analysis. Interleukin Genetics reported sales of $2.51 million for the year ending December of 2016. This represents an increase of 74.4% versus 2015, when the company's sales were $1.44 million.
  Stock Performance Chart for Interleukin Genetics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (12/22/2017): .00
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks -47.1%  
4 Weeks 12.5%   52 Weeks -96.5%  
Interleukin Genetics, Inc. Key Data:
  Ticker: ILIU Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 2,513,456
(Year Ending Jan 2017).
Employees: 27
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.